Trevi Therapeutics Inc. – Filings and Transcripts

NASDAQ: TRVI
Share price (8/6/26): $18.50
Market cap (8/6/26): $2.627 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Mathers Edward T

Colangelo Dominick

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Updates

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Business Updates

Announces Pricing of $150 Million Underwritten Offering of Common Stock

Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC